A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel
Clinical trial NCT04035473 · COMPLETED
Trial details
- NCT number
- NCT04035473
- Sponsor
- Athenex, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2019-03-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.